Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

View source ↗

Summary

A post-market registry study evaluating the RefluxStop device for gastroesophageal reflux disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RefluxStop

Snippet

Sponsor: Implantica CE Reflux Ltd. | Conditions: Gastroesophageal Reflux Disease (GERD) | Status: RECRUITING